Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus

Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence

(2016) Mari Hangai et al.   Journal of Atherosclerosis and Thrombosis

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

(2015) Faiez Zannad et al.   LANCET

The Association Between Skin Autofluorescence and Vascular Complications in Chinese Patients With Diabetic Foot Ulcer

(2015) Chuanbo Liu et al.   International Journal of Lower Extremity Wounds

Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

(2013) M. Afkarian et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Skin Autofluorescence, a Non-Invasive Marker for AGE Accumulation, Is Associated with the Degree of Atherosclerosis

(2013) Martijn A. M. den Dekker et al.   PLoS One

Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study

(2012) M. J. Noordzij et al.   DIABETIC MEDICINE

Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes

(2011) K. Tanaka et al.   DIABETIC MEDICINE

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease

(2011) Marjon J. Noordzij et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Reference Values of Skin Autofluorescence

(2010) M. Koetsier et al.   Diabetes Technology & Therapeutics

Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus

(2009) H. L. Lutgers et al.   DIABETOLOGIA